最新の特集記事
Calling for Policies to Support the Rare Disease Community in NZ
Health advocates highlight the urgent need to address challenges faced by people living with a rare disease
特集記事
Pacing the Pandemic, One Mutation at a Time
The ongoing story of COVID-19 surveillance
NEJM Study Shows WGS Improves Molecular Profiling
Side-by-side comparison shows WGS produced more accurate results in less time and at a similar cost
Illuminating Rare Disease
Bringing to light the challenges and hopes for the rare disease community
Shriners Hospitals Launches Ambitious Sequencing Initiative
Genomic luminaries Drs. Marc Lalande and Kamran Shazand establish the Genomics Institute
Press Releases
In the News
| 日付 | 論文 | タイトル |
|---|---|---|
| 2021/02/25 | BioPharma Reporter | German program using whole genome sequencing to diagnose rare diseases and cancer risk |
| 2021/02/25 | Kaiser Health News | Have a Case of a Covid Variant? No One Is Going to Tell You |
| 2021/02/17 | Cambridge Independent | Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge |
| 2021/02/17 | Bloomberg Technology | Illumina's deSouza on Tech Growth and Need for a Bio Force |
| 2021/02/17 | Associated Press | Government rushes virus gene-mapping as mutations spread |
Additional Resources
Investor Information
Careers at Illumina
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsPress Contacts
If you are a member of the media:
- Email pr@illumina.com
- Tel. 858.882.6822
If you are not a member of the media, please visit Contact Us.